Austin clinical-stage biopharma company Lung Therapeutics and Taiho Pharma in Japan announce exclusive license agreement for LTI-01 to treat LPE.
( read original story …)
The Japan News
Austin clinical-stage biopharma company Lung Therapeutics and Taiho Pharma in Japan announce exclusive license agreement for LTI-01 to treat LPE.
( read original story …)